Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

OBJECTIVE: In the SOLANA trial, we sought to physiologically characterize benralizumab’s onset of effect and maintenance of that effect for patients with severe eosinophilic asthma. METHODS: SOLANA (NCT02869438) was a multicenter, randomized, double-blind, parallel-group, placebo-controlled, Phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Panettieri, Reynold A, Welte, Tobias, Shenoy, Kartik V, Korn, Stephanie, Jandl, Margret, Kerwin, Edward M, Feijoo, Rosa, Barker, Peter, Olsson, Richard F, Martin, Ubaldo J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034961/
https://www.ncbi.nlm.nih.gov/pubmed/32110060
http://dx.doi.org/10.2147/JAA.S240044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034961/
https://www.ncbi.nlm.nih.gov/pubmed/32110060
http://dx.doi.org/10.2147/JAA.S240044

Ejemplares similares